TY - JOUR
T1 - Antihyperalgesic effects of spinal cannabinoids
AU - Richardson, Jennelle Durnett
AU - Aanonsen, Lin
AU - Hargreaves, Kenneth M.
N1 - Funding Information:
SR 141716A was a gift from Sanofi Recherché (Montpellier, France). This work was supported by a predoctoral grant from the Howard Hughes Medical Institute (JDR) and by NIH DE9860 (KMH). The authors wish to thank Catherine Harding-Rose and Mary Ann Sabino for technical assistance.
PY - 1998/3/19
Y1 - 1998/3/19
N2 - Cannabinoids have been widely reported to produce antinociception in models such as tail flick and hot plate. However, their role in modulating thermal hyperalgesia is unknown. The potency of some drugs, such as the opioids, increases during hyperalgesia. Thus, we evaluated whether there is a change in the effectiveness of intrathecal cannabinoids with hyperalgesia. Additionally, we evaluated whether cannabinoids could inhibit capsaicin- evoked neurosecretion from isolated rat spinal cord. Our results indicate that 1 fmol anandamide (i.t.) completely blocked carrageenan-induced thermal hyperalgesia. However, anandamide at doses as high as 100 pmol had no effect on thermal latencies in normal animals. Additionally, anandamide inhibited K+- as well as capsaicin-evoked immunoreactive calcitonin gene-related peptide release. Finally, cannabinoid receptors were identified in sensory neurons. Collectively, these results indicate that there is an increased effectiveness of modulation of thermal nociceptive thresholds by spinal cannabinoids during hyperalgesia. This antihyperalgesic effect may be the result of cannabinoid-induced inhibition of neurosecretion from certain primary afferent fibers.
AB - Cannabinoids have been widely reported to produce antinociception in models such as tail flick and hot plate. However, their role in modulating thermal hyperalgesia is unknown. The potency of some drugs, such as the opioids, increases during hyperalgesia. Thus, we evaluated whether there is a change in the effectiveness of intrathecal cannabinoids with hyperalgesia. Additionally, we evaluated whether cannabinoids could inhibit capsaicin- evoked neurosecretion from isolated rat spinal cord. Our results indicate that 1 fmol anandamide (i.t.) completely blocked carrageenan-induced thermal hyperalgesia. However, anandamide at doses as high as 100 pmol had no effect on thermal latencies in normal animals. Additionally, anandamide inhibited K+- as well as capsaicin-evoked immunoreactive calcitonin gene-related peptide release. Finally, cannabinoid receptors were identified in sensory neurons. Collectively, these results indicate that there is an increased effectiveness of modulation of thermal nociceptive thresholds by spinal cannabinoids during hyperalgesia. This antihyperalgesic effect may be the result of cannabinoid-induced inhibition of neurosecretion from certain primary afferent fibers.
KW - Cannabinoid
KW - Capsaicin
KW - Hyperalgesia
KW - Spinal cord
KW - Superfusion
KW - Trigeminal ganglion
UR - http://www.scopus.com/inward/record.url?scp=0032546267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032546267&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(97)01621-X
DO - 10.1016/S0014-2999(97)01621-X
M3 - Article
C2 - 9600630
AN - SCOPUS:0032546267
SN - 0014-2999
VL - 345
SP - 145
EP - 153
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2
ER -